Blockade and reversal of endothelin-induced constriction in pial arteries from human brain

Stroke

Volumn 30, Issue 3, 1999, Pages 638-643

  Pierre, Lisa N ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Calcium channel blockers; Cerebral arteries; Endothelins; Vasoconstriction

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; NIMODIPINE; SARAFOTOXIN S6C;

ADULT; ARTERY CONSTRICTION; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MALE; PIA ARTERY; PRIORITY JOURNAL;

EID: 0032967302     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.3.638     Document Type: Article

References (46)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki G, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.
3. Arai H, Aramori I., Hiroaki O, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-732.
4. Sakurai T, Yanagisawa M, Yakuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Cloning of cDNA encoding a non-peptide-selective subtype of endothelin receptor. Nature. 1990;348:732-735.
5. Hardebo JE, Kahrstrom J, Owman C, Salford LG. Endothelin is a potent constrictor of human intracranial arteries and veins. Blood Vessels. 1989; 26:249-253.
6. Papadopoulos SM, Gilbert LL, Webb R, D'Amato CJ. Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm. Neurosurgery. 1990;26:810-815.
7. Adner M, Jansen I, Edvinsson L. Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries. J Auton Nerv Syst. 1994;49:S117-S121.
8. Feger GI, Schilling L, Ehrenreich H, Wahl M. Endothelin-induced contraction and relaxation of rat isolated basilar artery: effect of BQ123. J Cereb Blood Flow Metab. 1994;14:845-852.
9. Patel TR, Galbraith S, Graham DI, Hallak H, Doherty AM, McCulloch J. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cereb Blood Flow Metab. 1996;16:950-958.
10. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke. 1992;23: 1014-1016.
11. Seifert V, Loffler B-M, Zimmerman M, Roux S, Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1995;82:55-62.
12. Suzuki H, Sato S, Suzuki S, Takekoshi K, Ishihara N, Shimoda S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand. 1990;81:553-554.
13. A receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg. 1994;81:759-764.
14. Foley PL, Caner HH, Kassell NF, Lee KS. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery. 1994;34:108-113.
15. Pierre LN, Davenport AP. Endothelin receptors in pial arteries from human brain. Pharmacologist. 1997;39:78. Abstract.
16. A receptors in pial artery from human brain revealed by potent nonpeptide endothelin antagonist. Br J Pharmacol. 1997;122:15P. Abstract.
17. A receptors. Br J Pharmacol. 1994;111:4-6.
18. Bacon CR, Davenport AP. Endothelin receptors in human coronary artery and aorta. Br J Pharmacol. 1996;117:986-992.
19. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
20. A receptor antagonist. J Pharmacol Exp Ther. 1995;273:1410-1417.
21. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Takehiro F, Ozaki S, Nagase T, Nishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist BQ788. Proc Natl Acad Sci U S A. 1994;91:4892-4896.
22. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1949;14:48-58.
23. Kraus GE, Bucholz RD, Yoon K-W, Knuepfer MM, Smith KR. Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review. Surg Neurol. 1991;35:20-29.
24. Yamaura I, Tani E, Maeda Y, Minami N, Shindo H. Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg. 1992;76:99-105.
25. Zimmerman M, Seifert V, Loffler B-M, Stolke D, Stenzel W. Prevention of cerebral vasospasm after experimental subarachnoid haemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Neurosurgery. 1996;38:115-120.
26. Kim CJ, Bassiouny M, Macdonald RL, Weir B, Johns LM. Effect of BQ123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Stroke. 1996;27:1629-1633.
27. A receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci. 1993;52:1869-1874.
28. Nilsson T, Cantera L, Adner M, Edvinsson, L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery. 1997;40:346-353.
29. Balligand JL, Godfraind T. Effect of nisoldipine on contractions evoked by endothelin-1 in human isolated distal and proximal coronary arteries and veins. J Cardiovasc Pharmacol. 1994;24:618-625.
30. Pierre LN, Davenport AP. Vasoconstrictor endothelin receptors in human small coronary arteries in vitro. Br J Pharmacol. 1996;119:103P. Abstract.
31. B receptor-mediated contraction in human pulmonary resistance arteries. Br J Pharmacol. 1996;119:1125-1130.
32. Patel TR, McAuley MA, McCulloch J. Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist. Eur J Pharmacol. 1994;260:65-71.
33. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Hamaoki M, Kato H, Yazaki Y. Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 1990;159:1435-1440.
34. Kasuya H, Weir BKA, White DM, Stefansso K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth muscle cells. J Neurosurg. 1993;79:892-898.
35. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg. 1992;77:274-278.
36. Resink TJ, Hahn WA, Scott-Burden T, Powell J, Weber E, Buhler FR. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun. 1990;168:1303-1310.
37. Yoshimoto S, Ishizaki Y, Kurihara H, Sasaki T, Yanagisawa M, Yazaki Y, Masaki T, Takakura K, Murota S-i. Cerebral microvessel endothelium is producing endothelin. Brain Res. 1990;508:283-285.
38. Bacic F, Uematsu S, McCarron RM, Spatz M. Secretion of immunoreactive enothelin-1 by capillary and microvascular endothelium of human brain. Neurochem Res. 1992;17:699-702.
39. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991;88:1054-1057.
40. Lee M-E, de la Monte SM, Ng S-C, Bloch KD, Quertermous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest. 1990;86:141-147.
41. MacCumber MW, Ross CA, Snyder SH. Endothelin in brain: receptors, mitogenesis and biosynthesis in glial cells. Proc Nail Acad Sci U S A. 1990;87:2359-2363.
42. B receptors. J Pharmacol Exp Ther. 1997;280:1102-1108.
43. Godfraind T, Morel N, Dessy C. Calcium antagonists and vasoconstrictor effects in intracerebral microarterioles. Stroke. 1990:21(suppl IV):IV-59-IV-63.
44. Kazda S, Towart R. Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir (Wien). 1982;63: 259-265.
45. Ljunggren B, Brandt L, Saveland H. Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg. 1984;61:864-873.
46. Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, Foy PM, Humphrey PRD, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ. 1989;298:636-642.